UroGen Pharma Ltd. has grown revenue 27% a year over three years and 49% a year over five. Revenue growth, 3-year annual rate: +27% (Biotechnology median +21%). Revenue growth, 5-year rate: +49%, growth has slowed since the five-year average. Years of annual history on file: 11, FY2015 to FY2025, as filed.

URGNUroGen Pharma Ltd.

HealthcareUSD

$45.91

$16.4252 weeks$50.29

Is it growing?

Is URGN growing?

UroGen Pharma Ltd. has grown revenue 27% a year over three years and 49% a year over five.

+27%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +49%
Revenue growth, 5-year rate · +27% over three · growth has slowed since the five-year average
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›